Rod Raynovich's  Instablog

Rod Raynovich
Send Message
Rod Raynovich is an entrepreneur and executive with a focus on life science companies and medical technology trends.He has over 30 years executive experience including Abbott and JNJ and has been involved three successful start-ups. He has a B.S, from Penn State University and an MBA from... More
My company:
Raygent Capital
My blog:
  • Market Grinds Up- With Profit Taking In Some Biotech MO Stocks 0 comments
    Feb 12, 2013 3:07 PM | about stocks: ALXN, REGN, IBB

    Sell-Off Evident In Big Winners-Technicals Are Very Important In Here

    The 2013 rally trickled up today with the DOW and S&P up, but off its highs. NASDAQ is flat. The media trash talk has stoked up with many well known pundits and strategists urging caution but others repeating the worn mantra "don't fight the tape, don't fight the FED". And don't fight KIng Momentum until economic or earnings data show otherwise. As Kopin Tan says in this week's Barron's p13,... "Alas, a bullish tilt toward stocks is quickly becoming consensus".....And with big money socked away in bonds and money markets, many analysts believe it must flow into equities.

    The toppy biotech sector lost a little steam today with a sell-off in some favorite MO names:

    Alexion (ALXN ($90.50), Regeneron (REGN $168.30) off 1% and Medivation (MDVN $54.50) down 2.2%. But Biogen Idec (BIIB $165), Celgene (CELG $99), Gilead (GILD $40.79) and Pharmacyclics (PCYC $70.44) have held up lately. It looks very difficult to add Gilead (NASDAQ:GILD) on weakness which is ephemeral.

    Three of our focus stocks were up big today:

    Albany Molecular (AMRI $6.67) up 17.84% , Optimer (OPTR $11.53) up 1.77% and Response Genetics ( RGDX $1.40) up 6%.

    Illumina (NASDAQ:ILMN) was sued over its rejection of the $6.7B buyout from Roche. This should not matter as Illumina as a leader in genetic analysis tools should be worth much more in the future and this type of law suit has not been successful in the past. Investors agreed as the stock is flat today.

    The IBB has been hovering at the $1245 level for two weeks slightly off its late January high of $148.54 with a double top since November.

    Disclosure: I am long ILMN, OPTR, RGDX.

    Stocks: ALXN, REGN, IBB
Back To Rod Raynovich's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.